These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36199775)

  • 21. RasGRF1 participates in the protective effect of tanshinone IIA on depressive like behaviors of a chronic unpredictable mild stress induced mouse model.
    Cheng Y; An Q; Wang J; Wang Y; Dong J; Yin J
    Gene; 2020 Sep; 754():144817. PubMed ID: 32473965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
    Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
    Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone IIA regulates glycogen synthase kinase-3β-related signaling pathway and ameliorates memory impairment in APP/PS1 transgenic mice.
    Peng X; Chen L; Wang Z; He Y; Ruganzu JB; Guo H; Zhang X; Ji S; Zheng L; Yang W
    Eur J Pharmacol; 2022 Mar; 918():174772. PubMed ID: 35090935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
    Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R
    Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress.
    Xie Z; Zhou Y; Duan X; Yang L
    J Recept Signal Transduct Res; 2019 Apr; 39(2):134-145. PubMed ID: 31354004
    [No Abstract]   [Full Text] [Related]  

  • 26. Tanshinone IIA attenuates acetaminophen-induced hepatotoxicity through HOTAIR-Nrf2-MRP2/4 signaling pathway.
    Zhang X; Wang T; Yang Y; Li R; Chen Y; Li R; Jiang X; Wang L
    Biomed Pharmacother; 2020 Oct; 130():110547. PubMed ID: 32777703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
    Li M; Liu H; Zhao Q; Han S; Zhou L; Liu W; Li W; Gao F
    Cell Death Dis; 2021 Feb; 12(2):152. PubMed ID: 33542222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer.
    Zhang Y; Guo S; Fang J; Peng B; Zhang Y; Cao T
    Exp Ther Med; 2018 Oct; 16(4):2931-2937. PubMed ID: 30214513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA prevents acute lung injury by regulating macrophage polarization.
    Zhao JY; Pu J; Fan J; Feng XY; Xu JW; Zhang R; Shang Y
    J Integr Med; 2022 May; 20(3):274-280. PubMed ID: 35181255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation.
    Feng F; Cheng P; Zhang H; Li N; Qi Y; Wang H; Wang Y; Wang W
    Drug Des Devel Ther; 2019; 13():4275-4290. PubMed ID: 31908414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
    Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
    Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling.
    Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W
    Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone IIA attenuates cerebral aneurysm formation by inhibiting the NF‑κB‑mediated inflammatory response.
    Ma J; Hou D; Wei Z; Zhu J; Lu H; Li Z; Wang X; Li Y; Qiao G; Liu N
    Mol Med Rep; 2019 Aug; 20(2):1621-1628. PubMed ID: 31257487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.
    Wang WQ; Liu L; Sun HC; Fu YL; Xu HX; Chai ZT; Zhang QB; Kong LQ; Zhu XD; Lu L; Ren ZG; Tang ZY
    J Hematol Oncol; 2012 Nov; 5():69. PubMed ID: 23137165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
    Deng H; Yu B; Li Y
    Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
    Su CC
    Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
    Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
    J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.
    Yang Y; Liu L; Zhang X; Jiang X; Wang L
    Liver Int; 2020 Jan; 40(1):141-154. PubMed ID: 31571363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tanshinone IIA improves diabetes mellitus via the NF-κB-induced AMPK signal pathway.
    Yuan FY; Zhang M; Xu P; Xu D; Chen P; Ren M; Sun Q; Chen JY; Du J; Tang XL
    Exp Ther Med; 2018 Nov; 16(5):4225-4231. PubMed ID: 30344697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.